Coronary Blood Flow Regulation During General Anesthesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00866801|
Recruitment Status : Completed
First Posted : March 23, 2009
Last Update Posted : October 14, 2015
The central hypothesis in the present project is that general anesthesia may alter autonomic control such that perioperative coronary blood flow (CBF) is significantly disturbed.
These disturbances in coronary blood flow may contribute to the development of myocardial ischemia in the perioperative period. Furthermore, patients with an intrinsically altered autonomic sympathetic innervation, like diabetics, are even more prone to develop perioperative disturbances in coronary blood flow.
Here the researchers will investigate what the direct effects are of general and locoregional anesthesia on the CBF. Furthermore, the researchers aim to evaluate whether diabetic subjects show more disturbed CBF responses to anesthesia as compared to non-diabetics.
|Condition or disease|
|Myocardial Ischemia Autonomic Neuropathy Healthy Diabetes|
In response to intraoperative stress, increased autonomic sympathetic activity may alter myocardial oxygen demand. Under normal physiological circumstances, sympathetic stimulation increases myocardial blood flow via adrenergic coronary vasodilation. However, coronary vessels contain both α- and β-adrenoreceptors, and if the coronary circulation is impaired due to cardiovascular disease, unopposed adrenergic coronary vasoconstriction may contribute to ischemia. Anesthetics reduce both coronary blood flow (CBF) regulation and the sympathetic autonomic nervous activity. However, it is unclear whether anesthetic-related reductions in CBF are a result of inhibited autonomic sympathetic innervation. Data regarding alterations in myocardial blood flow in response to sympathetic stimulation during anesthesia provide conflicting results. Moffitt and Sethna showed in patients undergoing cardiac surgery that CBF decreased during sternotomy-induced sympathetic stimulation, whereas Kirno et al. showed an increase in coronary blood flow after sternotomy. To our best knowledge, coronary vascular responses to sympathetic stimulation in anesthetized healthy humans are lacking because of absence of reliable non-invasive measurement of myocardial blood flow. The introduction of non-invasive contrast-echocardiographic techniques that allow evaluation of regional myocardial blood flow enable evaluation of the relation between autonomic control and CBF during anesthesia.
Cardiac complications like myocardial ischemia remain one of the main causes of perioperative morbidity and mortality. Interestingly, the presence of cardiovascular autonomic neuropathy (CAN) strongly predicts abnormalities in myocardial perfusion and impaired coronary vasodilator responses to stress. This implies that symptoms of CAN, like resting tachycardia, orthostasis and alterations in heart rate variability may predict the degree of impairment of CBF regulation. Indeed, autonomic neuropathy as determined by heart rate variability predicted mortality in patients with coronary artery disease undergoing non-cardiac surgery, but the contribution of impaired coronary vasodilatory responses to these results has not been established. Clarification of the relation between autonomic control and CBF during anesthesia may not only contribute to our insight in pro-ischemic processes in the heart, but may lead to changes in preoperative assessment of patients at risk for perioperative ischemia, thereby reducing perioperative complications.
|Study Type :||Observational|
|Actual Enrollment :||45 participants|
|Official Title:||Cardiac Sympathetic Innervation and Coronary Blood Flow Regulation During General Anesthesia|
|Study Start Date :||April 2009|
|Actual Primary Completion Date :||February 2014|
|Actual Study Completion Date :||October 2014|
Healthy subjects scheduled for general anesthesia
Healthy with thoracic epidural anelgesia
Healthy subjects scheduled for general anesthesia and thoracic epidural analgesia
Subjects with diabetes scheduled for general anesthesia
Diabetes with autonomic neuropathy
Subjects with diabetes and cardiovascular autonomic neuropathy scheduled for general anesthesia
- Coronary flow reserve [ Time Frame: Within the first 3 days postoperatively ]
- Diabetic autonomic neuropathy [ Time Frame: Within the first 3 days postoperatively ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00866801
|VU University Medical Center|
|Amsterdam, Noord-Holland, Netherlands, 1007 MB|
|Principal Investigator:||Carolien SE Bulte, MD||VU University Medical Center|
|Principal Investigator:||R. A. Bouwman, MD, PhD||VU University Medical Center|
|Study Chair:||C. Boer, PhD||VU University Medical Center|
|Study Director:||S. A. Loer, MD, PhD, MSC||VU University Medical Center|
|Study Chair:||O. Kamp, MD, PhD||VU University Medical Center|
|Study Chair:||M. Diamant, MD, PhD||VU University Medical Center|